MATROS RICHARD K 4
4 · Sabra Health Care REIT, Inc. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
MATROS RICHARD K
DirectorChair, CEO and President
Transactions
- Award
Common Stock
[F1]2026-01-08+319,394→ 1,286,760 total - Tax Payment
Common Stock
[F2]2026-01-08$19.61/sh−223,944$4,391,542→ 1,062,816 total - Gift
Common Stock
[F3][F4]2026-01-08−232,936→ 829,880 total - Gift
Common Stock
[F3]2026-01-08+232,936→ 1,857,686 total(indirect: By Trust)
Footnotes (4)
- [F1]Represents the vesting of stock units granted under the Issuer's 2009 Performance Incentive Plan subject to a relative total stockholder return-based stock unit ("TSR units") award granted on December 27, 2022, including 67,146 shares with respect to dividend equivalent payments calculated based on the market value of the Issuer's Common Stock on the applicable dividend date. The Compensation Committee determined on January 8, 2026 that the number of TSR units earned was 200% of the target, based on the percentile ranking of the Issuer's total stockholder return among the total stockholder returns for the stocks comprising a group of pre-selected peer companies over the three-year performance period. Upon this determination, the TSR units vested immediately. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock on or about January 2, 2027, subject to earlier payment in the event of death, disability or change of control.
- [F2]Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the payout of previously vested restricted stock units previously granted to the reporting person.
- [F3]Represents shares of the Issuer's Common Stock acquired in connection with the payout of previously vested restricted stock units that have been transferred by the reporting person to the R&A Matros Revocable Trust.
- [F4]Consists of stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.
Signature
/s/ Michael Costa, as Attorney-in-Fact|2026-01-12